{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:38:16Z","timestamp":1791542296074,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH-R21","award":["AI170232-01"],"award-info":[{"award-number":["AI170232-01"]}]},{"name":"EDCTP2","award":["TMA2017SF-1955"],"award-info":[{"award-number":["TMA2017SF-1955"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00756-2","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T07:10:07Z","timestamp":1749539407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High prevalence of co-infections with latent tuberculosis, syphilis and hepatitis B and C among people with HIV in Ghana: a call for integrating screening into routine care"],"prefix":"10.1186","volume":"22","author":[{"given":"Helena","family":"Lamptey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Odame","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zaab-Yen Abana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Twumasi","family":"Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim Mawufemor Kofi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzidzor Aku","family":"Attoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araba","family":"Abaidoo-Myles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Borteley","family":"Bortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Klutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Puplampu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Jessey","family":"Ganu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Oliver-Commey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Yayra","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Boateng","family":"Kyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"6","key":"756_CR1","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, Infection HIV, et al. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020;3(6):2000\u201316.","journal-title":"JAMA Netw Open"},{"key":"756_CR2","doi-asserted-by":"crossref","unstructured":"Trickey A, Glaubius R, Pantazis N, Zangerle R, Wittkop L, Vehreschild J et al. Estimation of improvements in mortality in spectrum among adults with HIV receiving antiretroviral therapy in high-income countries. J Acquir Immune Defic Syndr (1999).. 2024;95:e89 - e96.","DOI":"10.1097\/QAI.0000000000003326"},{"key":"756_CR3","unstructured":"Remya, K. Effectiveness of antiretroviral therapy in HIV positive patients by monitoring CD4\u2009+\u2009T lymphocytes count. Int J Sci Res (IJSR). 2023."},{"key":"756_CR4","doi-asserted-by":"crossref","unstructured":"Gobran S, Ancu\u021ba P, Shoukry N. A Tale of two viruses: immunological insights into HCV\/HIV coinfection. Front Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.726419"},{"issue":"1","key":"756_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/QAI.0000000000002528","volume":"86","author":"S Pahwa","year":"2021","unstructured":"Pahwa S, Deeks S, Zou S, Tomitch N, Miller-Novak L, Caler E, et al. NIH workshop on HIV-associated comorbidities, coinfections, and complications: summary and recommendation for future research. JAIDS J Acquir Immune Defic Syndr. 2021;86(1):11\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4103\/ijmr.IJMR_1151_16","volume":"147","author":"V Sharma","year":"2018","unstructured":"Sharma V, Ramachandran V, Mogha N, Bharadwaj M, Hepatitis B. C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study. Indian J Med Res. 2018;147:588\u201393.","journal-title":"Indian J Med Res"},{"key":"756_CR7","doi-asserted-by":"crossref","unstructured":"Seyoum E, Demissie M, Worku A, Mulu A, Abdissa A, Berhane Y. HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in addis ababa: A retrospective cross-sectional study. PLoS ONE. 2022;17.","DOI":"10.1371\/journal.pone.0267230"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0255-0857(21)01946-0","volume":"26 2","author":"A Mahajan","year":"2008","unstructured":"Mahajan A, Tandon V, Verma S, Singh J, Sharma M. Prevalence of tuberculosis, hepatitis B, hepatitis C and syphilis co-infections among HIV\/AIDS patients. Ind J Med Microbiol. 2008;26 2:196\u20137.","journal-title":"Ind J Med Microbiol"},{"key":"756_CR9","doi-asserted-by":"crossref","unstructured":"Bruchfeld J, Correia-Neves M, K\u00e4llenius G, Tuberculosis, Coinfection HIV. Cold Spring Harbor Perspect Med. 2015;5(7).","DOI":"10.1101\/cshperspect.a017871"},{"key":"756_CR10","doi-asserted-by":"crossref","unstructured":"Aliyu G, El-Kamary SS, Abimiku AG, Blattner WA, Charurat ME. Demography and the dual epidemics of tuberculosis and HIV: analysis of cross-sectional data from Sub-Saharan Africa. PLoS ONE. 2018;13.","DOI":"10.1371\/journal.pone.0191387"},{"key":"756_CR11","doi-asserted-by":"crossref","unstructured":"Msomi N, Naidoo K, Yende-Zuma N, Padayatchi N, Govender K, Singh JA et al. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. BMC Infect Dis. 2020;20.","DOI":"10.1186\/s12879-020-05575-6"},{"issue":"3","key":"756_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"27","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat. 2020;27(3):294\u2013315.","journal-title":"J Viral Hepat"},{"issue":"42","key":"756_CR13","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","volume":"21","author":"R Zampino","year":"2015","unstructured":"Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941\u201353.","journal-title":"World J Gastroenterol"},{"key":"756_CR14","unstructured":"WHO. Viral hepatitis B and C burden of disease, policy adoption and implementation status in WHO regions. 2024. 2024."},{"issue":"1","key":"756_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12879-017-2598-z","volume":"17","author":"E Osei","year":"2017","unstructured":"Osei E, Der J, Owusu R, Kofie P, Axame WK. The burden of HIV on tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for tuberculosis control. BMC Infect Dis. 2017;17(1):504.","journal-title":"BMC Infect Dis"},{"key":"756_CR16","doi-asserted-by":"crossref","unstructured":"Fofana DB, Somboro AM, Maiga M, Kampo MI, Diakit\u00e9 B, Cissoko Y et al. Hepatitis B virus in West African children: systematic review and Meta-Analysis of HIV and other factors associated with hepatitis B infection. Int J Environ Res Public Health. 2023;20(5).","DOI":"10.3390\/ijerph20054142"},{"key":"756_CR17","doi-asserted-by":"crossref","unstructured":"Hung RKY, Patel N, Fox J, Cosgrove CA, Pett S, Burns FM et al. Prevalence of hiv\/hepatitis B and hiv\/hepatitis C coinfection among people of east, south, central and West African ancestry in the united Kingdom. AIDS. 2021.","DOI":"10.1097\/QAD.0000000000002929"},{"key":"756_CR18","doi-asserted-by":"crossref","unstructured":"Bivigou-Mboumba B. Human Immunodeficiency Virus-Hepatitis B Virus (HIV-HBV) Coinfection. Advances in HIV and AIDS Control. 2018.","DOI":"10.5772\/intechopen.78567"},{"key":"756_CR19","doi-asserted-by":"crossref","unstructured":"Sarmati L, Malagnino V. HBV infection in HIV-Driven immune suppression. Viruses. 2019;11(11).","DOI":"10.3390\/v11111077"},{"key":"756_CR20","doi-asserted-by":"crossref","unstructured":"Kenfack-Momo R, Kenmoe S, Takuissu G, Ebogo-Belobo J, Kengne-Nd\u00e9 C, Mbaga D et al. Epidemiology of hepatitis B virus and\/or hepatitis C virus infections among people living with human immunodeficiency virus in africa: A systematic review and meta-analysis. PLoS ONE. 2022;17.","DOI":"10.1371\/journal.pone.0269250"},{"issue":"12","key":"756_CR21","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong M, et al. Research priorities for an HIV cure: international AIDS society global scientific strategy 2021. Nat Med. 2021;27(12):2085\u201398.","journal-title":"Nat Med"},{"issue":"2","key":"756_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/v16020219","volume":"16","author":"W Mu","year":"2024","unstructured":"Mu W, Patankar V, Kitchen S, Zhen A. Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection. Viruses. 2024;16(2):219.","journal-title":"Viruses"},{"key":"756_CR23","doi-asserted-by":"crossref","unstructured":"He Y, Lin W, Gu F, Lan X, Li L. Co-infection with hepatitis B and human immunodeficiency virus: epidemiology, pathogenesis, and treatment. Infectious Diseases & Immunity; 2024.","DOI":"10.1097\/ID9.0000000000000123"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","volume":"8","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Lin P, Cheng N. HBV\/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med (Lausanne). 2021;8:713981.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"756_CR25","doi-asserted-by":"publisher","first-page":"e0207787","DOI":"10.1371\/journal.pone.0207787","volume":"13","author":"PR Abraham","year":"2018","unstructured":"Abraham PR, Devalraju KP, Jha V, Valluri VL, Mukhopadhyay S. PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection. PLoS ONE. 2018;13(11):e0207787.","journal-title":"PLoS ONE"},{"issue":"10","key":"756_CR26","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1172\/JCI136502","volume":"130","author":"SR Ganatra","year":"2020","unstructured":"Ganatra SR, Buc\u015fan AN, Alvarez X, Kumar S, Chatterjee A, Quezada M, et al. Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J Clin Investig. 2020;130(10):5171\u20139.","journal-title":"J Clin Investig"},{"issue":"8","key":"756_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ebiom.2015.06.017","volume":"2","author":"I Latorre","year":"2015","unstructured":"Latorre I, Dom\u00ednguez J. Dormancy antigens as biomarkers of latent tuberculosis infection. EBioMedicine. 2015;2(8):790\u20131.","journal-title":"EBioMedicine"},{"issue":"4","key":"756_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ebiom.2015.03.005","volume":"2","author":"ZA Sullivan","year":"2015","unstructured":"Sullivan ZA, Wong EB, Ndung\u2019u T, Kasprowicz VO, Bishai WR. Latent and active tuberculosis infection increase immune activation in individuals Co-Infected with HIV. EBioMedicine. 2015;2(4):334\u201340.","journal-title":"EBioMedicine"},{"issue":"1","key":"756_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12981-020-00320-0","volume":"17","author":"J Xun","year":"2020","unstructured":"Xun J, Qi T, Zou L, Tang Q, Shen Y, Yang J, et al. Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir. AIDS Res Ther. 2020;17(1):63.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"756_CR30","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1038\/s41598-019-41788-9","volume":"9","author":"MR L\u00f3pez-Huertas","year":"2019","unstructured":"L\u00f3pez-Huertas MR, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, S\u00e1nchez-Carrillo M, Mart\u00ednez-Rom\u00e1n P, et al. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study. Sci Rep. 2019;9(1):5606.","journal-title":"Sci Rep"},{"issue":"9","key":"756_CR31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/v16091484","volume":"16","author":"M Marra","year":"2024","unstructured":"Marra M, Catalano A, Sinicropi MS, Ceramella J, Iacopetta D, Salpini R, et al. New therapies and strategies to curb HIV infections with a focus on macrophages and reservoirs. Viruses. 2024;16(9):1484.","journal-title":"Viruses"},{"issue":"3","key":"756_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/v16030321","volume":"16","author":"I Navasardyan","year":"2024","unstructured":"Navasardyan I, Miwalian R, Petrosyan A, Yeganyan S, Venketaraman V. HIV\u2013TB coinfection: current therapeutic approaches and drug interactions. Viruses. 2024;16(3):321.","journal-title":"Viruses"},{"key":"756_CR33","doi-asserted-by":"crossref","unstructured":"Ruangtragool L, Silver R, Machiha A, Gwanzura L, Hakim AJ, Lupoli K et al. Factors associated with active syphilis among men and women aged 15 years and older in the Zimbabwe Population-based HIV impact assessment (2015\u20132016). PLoS ONE. 2022;17.","DOI":"10.1371\/journal.pone.0261057"},{"issue":"9","key":"756_CR34","doi-asserted-by":"publisher","first-page":"e0310909","DOI":"10.1371\/journal.pone.0310909","volume":"19","author":"C Guure","year":"2024","unstructured":"Guure C, Puplampu AE, Dery S, Abu-Ba\u2019are GR, Afagbedzi SK, Ayisi Addo S, et al. Syphilis among HIV-positive men who have sex with men in ghana: the 2023 biobehavioral survey. PLoS ONE. 2024;19(9):e0310909.","journal-title":"PLoS ONE"},{"issue":"1","key":"756_CR35","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1186\/s12889-020-09984-9","volume":"20","author":"A Haule","year":"2020","unstructured":"Haule A, Msemwa B, Mgaya E, Masikini P, Kalluvya S. Prevalence of syphilis, neurosyphilis and associated factors in a cross-sectional analysis of HIV infected patients attending Bugando medical centre, mwanza, Tanzania. BMC Public Health. 2020;20(1):1862.","journal-title":"BMC Public Health"},{"key":"756_CR36","unstructured":"Commission GA. Ghana Aids Commission. National HIV and AIDS strategic plan 2021\u20132025. 2020."},{"issue":"1","key":"756_CR37","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.jve.2020.100027","volume":"7","author":"EY Bonney","year":"2021","unstructured":"Bonney EY, Lamptey H, Aboagye JO, Zaab-Yen Abana C, Boateng AT, Quansah DNK, et al. Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research. J Virus Eradication. 2021;7(1):100027.","journal-title":"J Virus Eradication"},{"issue":"5","key":"756_CR38","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB gold plus performance in contact screening. Eur Respir J. 2016;48(5):1411\u20139.","journal-title":"Eur Respir J"},{"issue":"5","key":"756_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1513\/AnnalsATS.201905-407RL","volume":"17","author":"RK Gupta","year":"2020","unstructured":"Gupta RK, Kunst H, Lipman M, Noursadeghi M, Jackson C, Southern J, et al. Evaluation of QuantiFERON-TB gold plus for predicting incident tuberculosis among recent contacts: A prospective cohort study. Ann Am Thorac Soc. 2020;17(5):646\u201350.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"756_CR40","doi-asserted-by":"publisher","first-page":"30617","DOI":"10.1038\/srep30617","volume":"6","author":"L Yi","year":"2016","unstructured":"Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, et al. Evaluation of QuantiFERON-TB gold plus for detection of Mycobacterium tuberculosis infection in Japan. Sci Rep. 2016;6(1):30617.","journal-title":"Sci Rep"},{"key":"756_CR41","doi-asserted-by":"crossref","unstructured":"Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L et al. QuantiFERON TB gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019.","DOI":"10.1016\/j.jinf.2019.08.018"},{"key":"756_CR42","doi-asserted-by":"publisher","first-page":"690","DOI":"10.5588\/ijtld.16.0764","volume":"21","author":"L Telisinghe","year":"2017","unstructured":"Telisinghe L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, Cheeba-Lengwe M, Chiwele K, et al. The sensitivity of the QuantiFERON\u00ae-TB gold plus assay in Zambian adults with active tuberculosis. Int J Tuberc Lung Dis. 2017;21:690\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"756_CR43","volume-title":"Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection: A systematic review and Meta-analysis","author":"C Oh","year":"2020","unstructured":"Oh C, Ortiz-Brizuela E, Bastos M, Menzies D. Comparing the diagnostic performance of QFT-Plus to other tests of latent tuberculosis infection: A systematic review and Meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America; 2020."},{"key":"756_CR44","doi-asserted-by":"crossref","unstructured":"Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S et al. Relevance of QuantiFERON-TB gold plus and Heparin-Binding hemagglutinin Interferon-\u03b3 release assays for monitoring of pulmonary tuberculosis clearance: A multicentered study. Front Immunol. 2021;Volume 11\u20132020.","DOI":"10.3389\/fimmu.2020.616450"},{"key":"756_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12981-016-0107-x","volume":"13","author":"AA Agyeman","year":"2016","unstructured":"Agyeman AA, Ofori-Asenso R. Prevalence of HIV and hepatitis B coinfection in ghana: a systematic review and meta-analysis. AIDS Res Ther. 2016;13:23.","journal-title":"AIDS Res Ther"},{"key":"756_CR46","doi-asserted-by":"crossref","unstructured":"Bonsu EBO, Addo IY, Adjei BN, Alhassan MM, Nakua E. Prevalence, treatment outcomes and determinants of TB\u2013HIV coinfection: a 10-year retrospective review of TB registry in Kwabre East municipality of Ghana. BMJ Open. 2023;13.","DOI":"10.1136\/bmjopen-2022-067613"},{"key":"756_CR47","first-page":"4587179","volume":"2020","author":"VA Avoka","year":"2020","unstructured":"Avoka VA, Osei E. Evaluation of TB\/HIV collaborative activities: the case of South Tongu district, Ghana. Tuberc Res Treat. 2020;2020:4587179.","journal-title":"Tuberc Res Treat"},{"key":"756_CR48","doi-asserted-by":"crossref","unstructured":"Hayibor KM, Bandoh D, Asante-Poku A, Kenu E. Predictors of Adverse TB Treatment Outcome among TB\/HIV Patients Compared with Non-HIV Patients in the Greater Accra Regional Hospital from 2008 to 2016. Tuberculosis Research and Treatment. 2020;2020.","DOI":"10.1155\/2020\/1097581"},{"key":"756_CR49","doi-asserted-by":"crossref","unstructured":"Mekonen H, Negesse A, Dessie G, Desta M, Mihiret GT, Tarik YD et al. Impact of HIV coinfection on tuberculosis treatment outcomes in ethiopia: a systematic review and meta-analysis. BMJ Open. 2024;14.","DOI":"10.1136\/bmjopen-2024-087218"},{"issue":"8","key":"756_CR50","doi-asserted-by":"publisher","first-page":"e0301305","DOI":"10.1371\/journal.pone.0301305","volume":"19","author":"V Dos Muchangos","year":"2024","unstructured":"Dos Muchangos V, Chambal L, Nilsson C, Sevene E. HIV and hepatitis B virus co-infection in mozambique: policy review and health professionals\u2019 knowledge and practices. PLoS ONE. 2024;19(8):e0301305.","journal-title":"PLoS ONE"},{"key":"756_CR51","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.ctarc.2019.100129","volume":"19","author":"L Cunha","year":"2019","unstructured":"Cunha L, Carrilho C, Bhatt N, Loforte M, Maueia C, Fernandes F, et al. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients. Cancer Treat Res Commun. 2019;19:100129.","journal-title":"Cancer Treat Res Commun"},{"key":"756_CR52","doi-asserted-by":"crossref","unstructured":"Osei-Yeboah J, Lokpo S, Ussher F, Orish V, Hamid A, Dakorah M et al. The epidemiology of human immunodeficiency virus (HIV) and syphilis in Ghana: A Five-Year Single Urban Site Parallel Population-Based Analysis vis-\u00e0-vis the Sentinel Survey. J Trop Med. 2018;2018.","DOI":"10.1155\/2018\/6574731"},{"issue":"1","key":"756_CR53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1186\/s12889-023-15948-6","volume":"23","author":"CZY Abana","year":"2023","unstructured":"Abana CZY, Kushitor DK, Asigbee TW, Parbie PK, Ishikawa K, Kiyono H, et al. Community based multi-disease health screening as an opportunity for early detection of HIV cases and linking them to care. BMC Public Health. 2023;23(1):1051.","journal-title":"BMC Public Health"},{"issue":"2","key":"756_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.9734\/ISRR\/2020\/v9i230112","volume":"9","author":"IO Okonko","year":"2020","unstructured":"Okonko IO, Adiele HCI, Awanye AM, Cookey TI, Onoh CC. Human immunodeficiency virus (HIV) and Treponema pallidum (Syphilis) Co-infection in Uyo. Nigeria Int STD Res Reviews. 2020;9(2):33\u201342.","journal-title":"Nigeria Int STD Res Reviews"},{"issue":"1","key":"756_CR55","first-page":"776","volume":"6","author":"K Arhin-Wiredu","year":"2024","unstructured":"Arhin-Wiredu K, Annor RB, Adusei-Mensah F, Sarfo B. HIV in Sunyani and peri-urban areas is associated with previous history of syphilis infection and multiple sexual partners-A cross-sectional study. Health Sci Investigations J. 2024;6(1):776\u201382.","journal-title":"Health Sci Investigations J"},{"issue":"3","key":"756_CR56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1600-0897.2010.00942.x","volume":"65","author":"KH Mayer","year":"2011","unstructured":"Mayer KH, Venkatesh KK. Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition. Am J Reprod Immunol. 2011;65(3):308\u201316.","journal-title":"Am J Reprod Immunol"},{"key":"756_CR57","doi-asserted-by":"crossref","unstructured":"Commission GA, Ghana AIDS. Commission. 95-95-95 program. Under the office of the President. 2022. 2022.","DOI":"10.30875\/9789287053749c057"},{"issue":"1","key":"756_CR58","doi-asserted-by":"publisher","first-page":"2271708","DOI":"10.1080\/16549716.2023.2271708","volume":"16","author":"DS Boakye","year":"2023","unstructured":"Boakye DS, Adjorlolo S. Achieving the UNAIDS 95-95-95 treatment target by 2025 in ghana: a myth or a reality? Global Health Action. 2023;16(1):2271708.","journal-title":"Global Health Action"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00756-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00756-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T07:10:17Z","timestamp":1749539417000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00756-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00756-2","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Boards of the Noguchi Memorial Institute for Medical Research (NMIMR-IRB-CPN 002\/18\u201319), Ghana Health Service (GHS-ERC: 013\/09\/19), and Korle-Bu Teaching Hospital Ethical Review Board (KBTHIRB\/00075\/2019). The Ethics Review Board of NMIMR holds a United States Government Federal Wide Assurance (FWAA00001824) from the Office for Human Research Protection in accordance with the Declaration of Helsinki. A declaration of free willingness to participate in the study and written informed consent were obtained from all study participants or guardians prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}